Literature DB >> 6352352

Biguanides. A review of history, pharmacodynamics and therapy.

G Schäfer.   

Abstract

This review on biguanides gives a general survey of biguanide actions on many metabolic models in vivo and in vitro. It focuses especially on the comparison of the 3 antidiabetic biguanides, of which metformin is discussed as the only oral antidiabetic biguanide useful in treatment of type-II diabetes with a minimum risk of side effects when applied in a well controlled regime. Pharmacokinetics, pharmacodynamics, hypotheses on the molecular mode of action, and implications for therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352352

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  30 in total

1.  Metformin: historical overview.

Authors:  Clifford J Bailey
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus.

Authors:  Christophe Bardin; Estelle Nobecourt; Etienne Larger; François Chast; Jean-Marc Treluyer; Saik Urien
Journal:  Eur J Clin Pharmacol       Date:  2012-01-25       Impact factor: 2.953

Review 4.  [Value of biguanide in therapy of diabetes mellitus].

Authors:  E Haupt; U Panten
Journal:  Med Klin (Munich)       Date:  1997-08-15

5.  Effects of insulin, biguanide antihyperglycaemic agents and beta-adrenergic agonists on pathways of myocardial proteolysis.

Authors:  D P Thorne; T D Lockwood
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

6.  Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations.

Authors:  F Gregorio; F Ambrosi; P Marchetti; S Cristallini; R Navalesi; P Brunetti; P Filipponi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

7.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.

Authors:  K Jones; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 9.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

10.  Spectrophotometric Quantitation of Metformin in Bulk Drug and Pharmaceutical Formulations using Multivariate Technique.

Authors:  M S Arayne; Najma Sultana; M H Zuberi; F A Siddiqui
Journal:  Indian J Pharm Sci       Date:  2009-05       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.